These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


241 related items for PubMed ID: 8521904

  • 1. Modification of behavioral effects of 8-hydroxy-2-(di-n-propylamino)tetralin following chronic ethanol consumption in the rat: evidence for the involvement of 5-HT1A receptors in ethanol dependence.
    Kleven M, Ybema C, Carilla E, Hamon M, Koek W.
    Eur J Pharmacol; 1995 Aug 15; 281(3):219-28. PubMed ID: 8521904
    [Abstract] [Full Text] [Related]

  • 2. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
    Scott PA, Chou JM, Tang H, Frazer A.
    J Pharmacol Exp Ther; 1994 Jul 15; 270(1):198-208. PubMed ID: 8035316
    [Abstract] [Full Text] [Related]

  • 3. Circadian rhythm in the response of central 5-HT1A receptors to 8-OH-DPAT in rats.
    Lu JQ, Nagayama H.
    Psychopharmacology (Berl); 1996 Jan 15; 123(1):42-5. PubMed ID: 8741953
    [Abstract] [Full Text] [Related]

  • 4. The behavioural, but not the hypothermic or corticosterone, response to 8-hydroxy-2-(DI-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat.
    Przegaliński E, Ismaiel AM, Chojnacka-Wójcik E, Budziszewska B, Tatarczyńska E, Błaszczyńska E.
    Neuropharmacology; 1990 Jun 15; 29(6):521-6. PubMed ID: 2143565
    [Abstract] [Full Text] [Related]

  • 5. Effect of the repeated administration of (+/-)-3,4-methylenedioxymethamphetamine on the behavioral response of rats to the 5-HT1A receptor agonist (+/-)-8-hydroxy-(di-n-propylamino)tetralin.
    Granoff MI, Ashby CR.
    Neuropsychobiology; 2001 Jan 15; 43(1):42-8. PubMed ID: 11150898
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 15; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 7. Antagonism of (+)WAY 100135 to behavioral, hypothermic and corticosterone effects induced by 8-OH-DPAT.
    Przegaliński E, Filip M, Budziszewska B, Chojnacka-Wójcik E.
    Pol J Pharmacol; 1994 Aug 15; 46(1-2):21-7. PubMed ID: 7981767
    [Abstract] [Full Text] [Related]

  • 8. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H, Liu Y, Malmberg A, Mohell N, Hacksell U, Lewander T.
    Eur J Pharmacol; 1996 May 15; 303(3):151-62. PubMed ID: 8813561
    [Abstract] [Full Text] [Related]

  • 9. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
    Tricklebank MD, Forler C, Fozard JR.
    Eur J Pharmacol; 1984 Nov 13; 106(2):271-82. PubMed ID: 6241568
    [Abstract] [Full Text] [Related]

  • 10. Chronic lithium treatment enhances the postsynaptic 5-HT1A receptor-mediated 5-HT behavioral syndrome induced by 8-OH-DPAT in rats via catecholaminergic systems.
    Uchitomi Y, Yamawaki S.
    Psychopharmacology (Berl); 1993 Nov 13; 112(1):74-9. PubMed ID: 7871012
    [Abstract] [Full Text] [Related]

  • 11. Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy.
    Prinssen EP, Koek W, Colpaert FC, Kleven MS.
    Behav Pharmacol; 2000 Jun 13; 11(3-4):299-305. PubMed ID: 11103884
    [Abstract] [Full Text] [Related]

  • 12. In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia.
    Bardin L, Tarayre JP, Koek W, Colpaert FC.
    Eur J Pharmacol; 2001 Jun 08; 421(2):109-14. PubMed ID: 11399266
    [Abstract] [Full Text] [Related]

  • 13. Food restriction and streptozotocin treatment decrease 5-HT1A and 5-HT2A receptor-mediated behavioral effects in rats.
    Li JX, France CP.
    Behav Pharmacol; 2008 Jul 08; 19(4):292-7. PubMed ID: 18622176
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the effects of 8-OH-DPAT pretreatment of different behavioural responses to 8-OH-DPAT.
    O'Connell MT, Curzon G.
    Eur J Pharmacol; 1996 Sep 26; 312(2):137-43. PubMed ID: 8894587
    [Abstract] [Full Text] [Related]

  • 15. A single pretreatment with 8-OH-DPAT reduces behavioral indices of serotonin 1A receptor activation in ovariectomized rats.
    Maswood N, Uphouse L.
    Neuropharmacology; 1997 Sep 26; 36(11-12):1725-32. PubMed ID: 9517444
    [Abstract] [Full Text] [Related]

  • 16. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S, Sharp T, Hacksell U.
    Eur J Pharmacol; 1989 Nov 07; 170(3):269-74. PubMed ID: 2533557
    [Abstract] [Full Text] [Related]

  • 17. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J, Sugimoto Y, Horisaka K.
    Eur J Pharmacol; 1988 Sep 23; 154(3):299-304. PubMed ID: 2976671
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of 5-hydroxytryptamine1a selective drugs on the 5-HT behavioral syndrome.
    Smith LM, Peroutka SJ.
    Pharmacol Biochem Behav; 1986 Jun 23; 24(6):1513-9. PubMed ID: 2942947
    [Abstract] [Full Text] [Related]

  • 19. The relation of central 5-HT1A and 5-HT2 receptors: low dose agonist-induced selective tolerance in the rat.
    Pranzatelli MR, Pluchino RS.
    Pharmacol Biochem Behav; 1991 Jun 23; 39(2):407-13. PubMed ID: 1835098
    [Abstract] [Full Text] [Related]

  • 20. Effects of cold stress on some 5-HT1A, 5-HT1C and 5-HT2 receptor-mediated responses.
    Zamfir O, Broqua P, Baudrie V, Chaouloff F.
    Eur J Pharmacol; 1992 Aug 25; 219(2):261-9. PubMed ID: 1385172
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.